These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia. Goff DC, Renshaw PF, Sarid-Segal O, Dreyfuss DA, Amico ET, Ciraulo DA. Biol Psychiatry; 1993 May 15; 33(10):700-6. PubMed ID: 8102552 [Abstract] [Full Text] [Related]
9. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist. Korsgaard S, Casey DE, Gerlach J, Hetmar O, Kaldan B, Mikkelsen LB. Arch Gen Psychiatry; 1982 Sep 15; 39(9):1017-21. PubMed ID: 6126170 [Abstract] [Full Text] [Related]
10. Clozapine for tardive dyskinesia in adolescents. Levkovitch Y, Kronenberg J, Kayser N, Zvyagelski M, Gaoni B, Gadoth N. Brain Dev; 1995 Sep 15; 17(3):213-5. PubMed ID: 7573764 [Abstract] [Full Text] [Related]
11. Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Bassitt DP, Louzã Neto MR. Eur Arch Psychiatry Clin Neurosci; 1998 Sep 15; 248(4):209-11. PubMed ID: 9810484 [Abstract] [Full Text] [Related]
12. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group. Psychopharmacology (Berl); 1986 Sep 15; 90(4):423-9. PubMed ID: 2880362 [Abstract] [Full Text] [Related]
13. Sulpiride in tardive dyskinesia. Casey DE, Gerlach J, Simmelsgaard H. Psychopharmacology (Berl); 1979 Sep 15; 66(1):73-7. PubMed ID: 44375 [Abstract] [Full Text] [Related]
14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ, Soares KV. Cochrane Database Syst Rev; 2000 Sep 15; (2):CD000459. PubMed ID: 10796546 [Abstract] [Full Text] [Related]
15. Effect of clozapine in severe tardive dyskinesia: a case report. Meltzer HY, Luchins DJ. J Clin Psychopharmacol; 1984 Oct 15; 4(5):286-7. PubMed ID: 6149239 [Abstract] [Full Text] [Related]
16. Oxiperomide in tardive dyskinesia. Casey DE, Gerlach J. J Neurol Neurosurg Psychiatry; 1980 Mar 15; 43(3):264-7. PubMed ID: 7373324 [Abstract] [Full Text] [Related]
17. High-dose destyrosine-gamma-endorphin in tardive dyskinesia. Korsgaard S, Casey DE, Gerlach J. Psychopharmacology (Berl); 1982 Mar 15; 78(3):285-6. PubMed ID: 6130557 [Abstract] [Full Text] [Related]
18. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB, Caligiuri MP. J Clin Psychiatry; 1996 Apr 15; 57(4):167-73. PubMed ID: 8601552 [Abstract] [Full Text] [Related]
19. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM, Yu SC, Lin CC. J Clin Psychiatry; 2003 Nov 15; 64(11):1342-8. PubMed ID: 14658949 [Abstract] [Full Text] [Related]
20. Buspirone in the treatment of tardive dyskinesia. Moss LE, Neppe VM, Drevets WC. J Clin Psychopharmacol; 1993 Jun 15; 13(3):204-9. PubMed ID: 8102622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]